Intratumoral CXCL13+CD160+CD8+T cells promote the formation of tertiary lymphoid structures to enhance the efficacy of immunotherapy in advanced gastric cancer

Abstract

BackgroundStage IV gastric cancer is a highly heterogeneous and lethal tumor with few therapeutic strategies. The combination of programmed cell death protein 1 inhibitors and chemotherapy is currently the standard frontline treatment regimen for advanced gastric cancer. Nevertheless, it remains a great challenge to screen the beneficiaries of immunochemotherapy and expand indications for this treatment regimen.MethodsWe conducted a pathological assessment to ascertain the importance of tertiary lymphoid structures based on the tissue samples collected from patients with stage IV gastric cancer (n=15) both prior to and following immunochemotherapy treatment. Additionally, we used spatial (n=10) and single-cell transcriptional analysis (n=97) to investigate the key regulators of tertiary lymphoid structures (TLSs). Multiplex immunofluorescence and image analysis (n=34) were performed to explore the association between tumor-infiltrating CXCL13+CD160+CD8+T cells and TLSs. The relationship between CXCL13+CD160+CD8+T cells and the responsiveness to immunotherapy was also evaluated by multiplex immunofluorescence and image analysis approaches (n=15). Furthermore, we explored the intrinsic characteristics of CXCL13+CD160+CD8+T cells through various experimental techniques, including quantitative reverse transcription-PCR, western blot, and flow cytometry.ResultsWe found that responders exhibited higher levels of TLSs and CXCL13+CD160+CD8+T cells in biopsy tissues prior to immunochemotherapy compared with non-responders. Following conversion therapy, responders also had a higher percentage of mature TLSs and a higher number of CXCL13+CD160+CD8+T cells in surgical resections. Moreover, we discovered that vitamin B6in CD160+CD8+T cells could reduce the ubiquitination modification of HIF-1α by MDM2, thereby attenuating the degradation of HIF-1α. Consequently, this led to the transcriptional upregulation of CXCL13 expression, facilitating the recruitment of CXCR5+B cells and the formation of TLSs.ConclusionThe number and maturity of TLSs, along with the extent of CXCL13+CD160+CD8+T-cell infiltration, might function as potential indicators for assessing the effectiveness of immunotherapy in treating gastric malignancies. Furthermore, our research suggests that vitamin B6could enhance the secretion of CXCL13 by CD160+CD8+T cells by reducing the degradation of HIF-1α. Additionally, we demonstrate that vitamin B6supplementation or targeting pyridoxal kinase could substantially improve the efficacy of immunotherapies for gastric cancer.